Micronoma Gets Breakthrough Device Designation for Liquid Biopsy Assay that Detects Lung Carcinoma
Micronoma announced its OncobiotaLUNG assay received the Breakthrough Device Designation from the U.S. FDA for lung carcinoma detection.
Read MorePosted by Andy Lundin | Jan 10, 2023 | Lung Cancer |
Micronoma announced its OncobiotaLUNG assay received the Breakthrough Device Designation from the U.S. FDA for lung carcinoma detection.
Read MorePosted by Andy Lundin | Jan 9, 2023 | Lung Cancer |
PrognomiQ unveiled results from multi-omics study demonstrating the power of diverse molecular biomarkers in the early cancer detection.
Read MorePosted by Andy Lundin | Jan 3, 2023 | Cancer, Diagnostic Technologies |
Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.
Read MorePosted by Andy Lundin | Jan 2, 2023 | Colorectal |
Guardant Health unveiled results from a 20,000 patient study evaluating the performance of its blood test for detecting colorectal cancer.
Read MorePosted by Andy Lundin | Dec 30, 2022 | Leukemia |
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read More